PathologyWatch is the groundbreaking leader of digital dermatopathology services. Through two programs, ValueWatch and BusinessWatch, dermatology clinics and hospitals can improve operational efficiency by speeding up workflow and improve patient outcomes by utilizing the PathologyWatch expert professional team and partner laboratory services. This can facilitate best-in-class reads and, in some cases, enable additional revenue to the practice by in-housing pathology. With an intuitive and easy-to-implement digital pathology solution that includes access to top-tier dermatopathologists and a streamlined clinical workflow that interfaces directly into the EMR, PathologyWatch brilliantly combines state-of-the-art technology and clinical decision making to deliver unprecedented patient care.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/11/20 | $5,000,000 | Series A |
Rock Creek Capital SpringTide Investments | undisclosed |
| 12/18/20 | $2,000,000 | Series A Extension |
BeniVC Bioventures GmbH Lateral Capital Neue Fund Sky Ventures | undisclosed |
